• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
      -
      -
      -
        Visualized Analysis Export Evaluation Conclusion Evaluation Progress
        Show  
        Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
        JYSB2500075 达雷妥尤单抗注射液(皮下注射) daratumumab Injection Biological Products Supplementary Application 2025-03-22 Cilag AG;Janssen-Cilag International NV view
        JYSB2500022 达雷妥尤单抗注射液(皮下注射) daratumumab Injection Biological Products Supplementary Application 2025-02-07 Cilag AG;Janssen-Cilag International NV view
        JYSB2300204 达雷妥尤单抗注射液(皮下注射) daratumumab Injection Biological Products Supplementary Application 2023-12-08 Cilag AG;Janssen-Cilag International NV view
        JYSB2300140 达雷妥尤单抗注射液(皮下注射) daratumumab Injection Biological Products Supplementary Application 2023-08-18 Cilag AG;Janssen-Cilag International NV view
        JYSB2200040 达雷妥尤单抗注射液(皮下注射) daratumumab Injection Biological Products Supplementary Application 2022-03-10 Cilag AG;Janssen-Cilag International NV view
        JYSB2200015 达雷妥尤单抗注射液(皮下注射) daratumumab Injection Biological Products Supplementary Application 2022-01-30 Cilag AG;Janssen-Cilag International NV view
        JXSS2500061 达雷妥尤单抗注射液(皮下注射) daratumumab Injection Biological Products(3.1) Import Drug Application 2025-05-14 Johnson & Johnson;Cilag AG;Janssen-Cilag International NV view
        JXSS2200013 达雷妥尤单抗注射液(皮下注射) daratumumab Injection Biological Products(3.1) Import Drug Application 2022-04-15 Cilag AG;Xian Janssen Pharmaceutical Ltd;Janssen-Cilag International NV view
        JXSS2000050 达雷妥尤单抗注射液(皮下注射) daratumumab Injection Biological Products(2.2) Import Drug Application 2020-11-06 西安杨森制药有限公司 Xian Janssen Pharmaceutical Ltd;Cilag AG;Janssen-Cilag International NV Certificate Issued 2021-10-11 view
        JXSL2300040 达雷妥尤单抗注射液(皮下注射) daratumumab Injection Biological Products(3.1) Import Drug Application 2023-02-23 Janssen-Cilag International NV;Johnson & Johnson (CHINA) Investment Ltd view
        JXSL2200010 达雷妥尤单抗注射液(皮下注射) daratumumab Injection Biological Products(3.4) Import Drug Application 2022-01-19 Janssen Research & Development LLC;Johnson & Johnson (CHINA) Investment Ltd view
        JXSB2300033 达雷妥尤单抗注射液(皮下注射) daratumumab Injection Biological Products(3.4) Supplementary Application 2023-03-28 Cilag AG;Janssen Research & Development LLC view
        You can use the filter after selecting or entering the search conditions.
        Using filter may affect the loading speed.
        ×××××××××
        Contact usFeed-backServiceTop
        You can use the filter after selecting or entering the search conditions.
        Using filter may affect the loading speed.